Literature DB >> 18413477

Muscle excitability abnormalities in Machado-Joseph disease.

Marcondes C França1, Anelyssa D'Abreu, Anamarli Nucci, Iscia Lopes-Cendes.   

Abstract

OBJECTIVES: To estimate the frequency of and to characterize muscle excitability abnormalities in Machado-Joseph disease (MJD).
DESIGN: Machado-Joseph disease is a common autosomal dominant cerebellar ataxia caused by an unstable CAG trinucleotide repeat expansion. Muscle cramps and fasciculations are frequent and sometimes disabling manifestations. However, their frequency and pathophysiological mechanisms remain largely unknown. Symptomatic patients with MJD (hereinafter MJD patients) with molecular confirmation were assessed prospectively. A standard questionnaire addressing clinical features of muscle cramps and fasciculations was used. The Cramps Disability Scale was used to quantify cramps-related disability. Patients underwent neurophysiological testing with routine techniques. F waves of the right median nerves were obtained, and persistence indexes were calculated. Four muscles (deltoid, first dorsal interossei, tibialis anterior, and vastus lateralis) were examined by needle electromyography. A semiquantitative scale (from 0 [no activity] to 4 [continuous activity]) was used to determine the frequency of rest fasciculations in each muscle.
RESULTS: Fifty MJD patients (29 men) were included in the study. Their mean age at examination was 46.3 years, their mean age at onset of the disease was 35 years, and the mean duration of disease was 11.2 years. Abnormal CAG(n) varied from 59 to 75 repeats. Forty-one patients presented with muscle cramps; in 10, this was their first symptom. The frequency of cramps varied between 1 and 90 episodes a week. For 15 patients, cramps were the chief complaint, frequently disturbing sleep or work (Cramps Disability Scale score, 2 or 3). Lower limbs were affected in 37 individuals, but unusual regions, such as the face and abdominal muscles, were also involved. Fasciculations were found in 25 individuals; in 8 patients, they included facial muscles. However, fasciculations were not a significant complaint for any of these patients. The clinical and neurophysiological profile of MJD patients with and without cramps was not significantly different. However, MJD patients with fasciculations had more severe damage to their peripheral nerves.
CONCLUSIONS: Muscle excitability abnormalities were found in 41 MJD patients (82%), and they were the presenting complaint in 10 (20%). They are related to altered excitability of peripheral motor axons, but mechanisms underlying cramps and fasciculations are possibly distinct in MJD patients.

Entities:  

Mesh:

Year:  2008        PMID: 18413477     DOI: 10.1001/archneur.65.4.525

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

2.  Neuromyotonia Confined to Faciobulbar Muscles in a Patient with Myasthenia Gravis.

Authors:  Dimitrios Parissis; Panagiotis Ioannidis; Georgios Papadopoulos; Dimitrios Karacostas
Journal:  Mov Disord Clin Pract       Date:  2017-02-01

Review 3.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

Review 4.  Another Perspective on Fasciculations: When is it not Caused by the Classic form of Amyotrophic Lateral Sclerosis or Progressive Spinal Atrophy?

Authors:  Marco Antonio Araujo Leite; Marco Orsini; Marcos R G de Freitas; João Santos Pereira; Fábio Henrique Porto Gobbi; Victor Hugo Bastos; Dionis de Castro Machado; Sergio Machado; Oscar Arrias-Carrion; Jano Alves de Souza; Acary Bulle Oliveira
Journal:  Neurol Int       Date:  2014-08-08

5.  Mouse ataxin-3 functional knock-out model.

Authors:  Pawel M Switonski; Agnieszka Fiszer; Katarzyna Kazmierska; Maciej Kurpisz; Wlodzimierz J Krzyzosiak; Maciej Figiel
Journal:  Neuromolecular Med       Date:  2010-10-14       Impact factor: 3.843

6.  Rescue of ATXN3 neuronal toxicity in Caenorhabditiselegans by chemical modification of endoplasmic reticulum stress.

Authors:  Yasmin Fardghassemi; Arnaud Tauffenberger; Sarah Gosselin; J Alex Parker
Journal:  Dis Model Mech       Date:  2017-12-19       Impact factor: 5.758

7.  SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage.

Authors:  Ingrid Faber; Alberto Rolim Muro Martinez; Thiago Junqueira Ribeiro de Rezende; Carlos Roberto Martins; Melina Pazian Martins; Charles Marques Lourenço; Wilson Marques; Celeste Montecchiani; Antonio Orlacchio; Jose Luiz Pedroso; Orlando Graziani Povoas Barsottini; Íscia Lopes-Cendes; Marcondes Cavalcante França
Journal:  Neuroimage Clin       Date:  2018-06-09       Impact factor: 4.881

Review 8.  Nonmotor symptoms in spinocerebellar ataxias (SCAs).

Authors:  Adriana Moro; Mariana Moscovich; Marina Farah; Carlos Henrique F Camargo; Hélio A G Teive; Renato P Munhoz
Journal:  Cerebellum Ataxias       Date:  2019-08-27

9.  Trehalose alleviates the phenotype of Machado-Joseph disease mouse models.

Authors:  Magda M Santana; Susana Paixão; Janete Cunha-Santos; Teresa Pereira Silva; Allyson Trevino-Garcia; Laetitia S Gaspar; Clévio Nóbrega; Rui Jorge Nobre; Cláudia Cavadas; Hagar Greif; Luís Pereira de Almeida
Journal:  J Transl Med       Date:  2020-04-09       Impact factor: 5.531

10.  Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease.

Authors:  Yanetza González-Zaldívar; Yaimeé Vázquez-Mojena; José M Laffita-Mesa; Luis E Almaguer-Mederos; Roberto Rodríguez-Labrada; Gilberto Sánchez-Cruz; Raúl Aguilera-Rodríguez; Tania Cruz-Mariño; Nalia Canales-Ochoa; Patrick MacLeod; Luis Velázquez-Pérez
Journal:  Cerebellum Ataxias       Date:  2015-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.